The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II assessment of carboplatin with etoposide and high-dose ifosfamide in rEECur, an international randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES).
 
Martin McCabe
Research Funding - Eisai (Inst)
 
Laura Kirton
No Relationships to Disclose
 
Maria Khan
No Relationships to Disclose
 
Sandra Strauss
Consulting or Advisory Role - Boehringer Ingelheim; Ceridwen Oncology; GlaxoSmithKline; InhibRx; Tessallate Bio
Speakers' Bureau - Boehringer Ingelheim
Travel, Accommodations, Expenses - Adaptimmune
 
Claudia Valverde Morales
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Deciphera; PharmaMar; Philogen
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Cristina Mata Fernandez
Consulting or Advisory Role - Ipsen; ITM Isotope Technologies Munich
Travel, Accommodations, Expenses - Novartis
 
Roberto Luksch
Consulting or Advisory Role - Recordati; SERB Pharmaceuticals
Travel, Accommodations, Expenses - Recoati Rare Diseases
 
Toni Ibrahim
Speakers' Bureau - Istituto Gentili
Research Funding - Ipsen (Inst); PharmaMar (Inst)
 
Uta Dirksen
Consulting or Advisory Role - Ipsen; Lilly (Inst); Recordati
 
Marianne Phillips
No Relationships to Disclose
 
Karsten Nysom
Consulting or Advisory Role - Lilly
 
Jukka Kanerva
Stock and Other Ownership Interests - Orion Oyj
 
Caroline Hutter
No Relationships to Disclose
 
Willemijn Breunis
No Relationships to Disclose
 
Nathalie Gaspar
Consulting or Advisory Role - EISAI; IPSEN
Travel, Accommodations, Expenses - Eisai; EISAI
 
Hans Gelderblom
Research Funding - Abbisko Therapeutics (Inst); AmmaxBio (Inst); Blueprint Medicines (Inst); Deciphera (Inst); InhibRx (Inst); Ipsen (Inst); SynOX (Inst)
Travel, Accommodations, Expenses - Abbisko Therapeutics (Inst); Merck (Inst)
 
Louise Hopkins
No Relationships to Disclose
 
Mark Winstanley
No Relationships to Disclose
 
Andrew Westwood
No Relationships to Disclose
 
Piers Gaunt
Research Funding - Astra Zeneca UK Limited, Bayer, Pfizer Limited; Astra Zeneca UK Limited, Bayer, Pfizer Limited (Inst)